Aika Miya

Has grant

Project Assistant Professor

Hokkaido University Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Aika Miya is a Project Assistant Professor at Hokkaido University Hospital in Japan. Her research focuses on type 2 diabetes, with recent articles examining the perception of glycemic events, lipid management in cardiovascular disease, and factors impacting glycemic control. Additionally, she has investigated the effects of treatments on non-alcoholic fatty liver disease and the complications arising from self-catheterization in diabetic patients.

Recent Grants

Grant: Close

2型糖尿病患者における膵β細胞機能の経年変化にともなう血糖変動不安定化の解明

Open Date: 2022-01-01

Close Date:

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Haruki Fujisawa

Fujita Health University

JAPAN

View details

KYUYONG CHO

Assistant Professor

Hokkaido University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aika Miya

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Perception of hyper-/hypoglycemia and its related factors in type 2 diabetes: a continuous glucose monitoring-based prospective observational study

Frequency and determinants of lipid management target achievement in primary prevention of cardiovascular disease in type 2 diabetes

Positive association between the proinsulin-to-C-peptide ratio and prolonged hyperglycemic time in type 2 diabetes

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis

Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study

Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)

Urethral injury related to peri‐urethral abscess as a complication of self‐catheterization in an older patient with type 2 diabetes

The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items (DASC‐8): A cross‐sectional study of elderly patients with diabetes

Letter to the Editor: False Hypercortisolemia Due to Abnormal Albumin-Cortisol Binding in a Patient with Familial Dysalbuminemic Hyperthyroxinemia

Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis

Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis

Collaborators (2)

Haruki Fujisawa

KYUYONG CHO

Make your next move.